The bioceramic orbital implant: Experience with 107 implants

Ophthalmic Plastic and Reconstructive Surgery

Volumn 19, Issue 2, 2003, Pages 128-135

  Jordan, David R ^a,c   Gilberg, Steven ^a   Mawn, Louise A ^b  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b VANDERBILT UNIVERSITY   (United States)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM OXIDE;

AGE; ARTICLE; BURNING SENSATION; CAUSE OF DEATH; CERAMIC PROSTHESIS; CONJUNCTIVA DISEASE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NEURITIS; ORBIT IMPLANT; PAIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PYOGENIC GRANULOMA; SURGEON; SURGICAL TECHNIQUE; TROCHLEAR NERVE; WOUND DRAINAGE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALUMINUM OXIDE; BIOCOMPATIBLE MATERIALS; CERAMICS; CHILD; EYE ENUCLEATION; EYE EVISCERATION; EYE MOVEMENTS; HUMANS; MIDDLE AGED; ORBIT; ORBITAL IMPLANTS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION;

EID: 0037347290     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000056027.63698.FE     Document Type: Article

References (58)

1. Perry AC. Advances in enucleation. Ophthal Plast Reconstr Surg 1991;4:173-82.
2. Byrd WA. Coralline hydroxyapatite orbital implant. Ophthal Practice 1991;9:262-6.
3. Dutton J. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
4. Hornblass A, Biesman BS, Eviator JA. Current techniques of enucleation: a survey of 5, 439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995;11:2:77-88.
5. Jordan DR. Anophthalmic orbital implants. Ophthalmol Clin North Am 2000;13:587-608.
6. Jordan DR, Munro SM, Brownstein S, et al. A synthetic hydroxyapatite implant: the so-called counterfeit implant. Ophthal Plast Reconstr Surg 1998;14:4:244-9.
7. Jordan DR, Gilberg S, Mawn L, et al. The synthetic hydroxyapatite implant: a report of 65 patients. Ophthal Plast Reconstr Surg 1998;14:4:250-5.
8. 3). Ophthal Plast Reconstr Surg 2001;17:3:184-90.
9. Jordan DR, Pelletier C, Gilberg S, et al. The Chinese hydroxyapatite implant. Ophthal Plast Reconstr Surg 1999;15:6:420-4.
10. Jordan DR, Hwang I, McEachren T, et al. The Brazilian implant. Ophthal Plast Reconstr Surg 2000;16:5:636-9.
11. Jordan DR, Hwang I, Gilberg S, et al. The Molteno M-Sphere. Ophthal Plast Reconstr Surg 2000;16:5:356-62.
12. Karesh JW, Dresner SC. High density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-96.
13. Goldberg RA, Dresner SC, Braslou RA, et al. Animal model of porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994;10:2:104-9.
14. Rubin PAD, Popham J, Rumeldts S, et al. Enhancement of the cosmetic and functional outcomes of enucleation with the conical orbital implant. Ophthalmology 1998;5:919-25.
15. Rubin PAD, Fay MM, Remulla HD. Primary placement of a motility coupling post in porous polyethylene orbital implants. Arch Ophthalmol 2000;118:826-32.
16. Anderson RL, Yen MT, Lucci LM, et al. The Quasi-integrated porous polyethylene orbital implant. Ophthal Plast Reconstr Surg 2002;18:1:50-5.
17. Deicasa R, Maw M, Bilyk J, et al. Gortex as an orbital implant material. Ophthal Plast Reconstr Surg 1998;14:6:425-31.
18. Hicks CR, Clayton AB, Vijayasekaran S, et al. Development of a poly (2-hydroxyethyl methacrylate) orbital implant allowing direct muscle attachment and tissue ingrowth. Ophthal Plast Reconstr Surg 1999;15:321-32.
19. Jordan DR, Mawn L, Gilberg S, et al. The Bioceramic implant: a new generation of porous orbital implants. Ophthal Plast Reconstr Surg 2000;16:5:347-53.
20. Christel P. Biocompatibility of surgical grade dense polycrystalline alumina. Clin Orthop 1992;282:10-8.
21. Boutin P, Christel P, Dorlot JM. The use of dense alumina-alumina ceramic combination in total hip replacement. J Biomed Mater Res 1988;22:1203-32.
22. Smith L. Ceramic-plastic material as a bone substitute. AMA Arch Surg 1963;87:653-61.
23. Jordan DR, Allen L, Ells A, et al. The use of Vicryl (polyglactin 910) for implantation of hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 1995;11:9.
24. Jordan DR, Ells A, Brownstein S, et al. The use of Vicryl mesh wrap for the implantation of hydroxyapatite orbital implants: an animal model. Can J Ophthalmol 1995;30:241-6.
25. Jordan DR, Klapper S. Wrapping hydroxyapatite implants. Ophthalmic Surg 1995;30:5:403-8.
26. Jordan DR, Klapper S, Gilberg S, et al. The use of Vicryl mesh in 200 porous orbital implants: a technique with few exposures. Ophthal Plast Reconstr Surg 2003;1:53-61.
27. Jordan DR, Khouri L. Evisceration with posterior sclerotomies. Can J Ophthalmol 2001;36:7:404-6.
28. Jordan DR, Klapper S. A new titanium peg system for use in hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 2000;16:5:380-7.
29. Jordan DR, Chan S, Mawn L, et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology 1999;106:505-12.
30. Pelletier C, Gilberg S, Jordan DR. Use of temporalis fascia for exposed hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 1998;14:198-203.
31. Campbell CA, Peet M, Ward NI. Vanadium and other trace elements in patients taking Lithium. Biol Psychiatry 1988;24:775-61.
32. Labat B, Chanson A, Frey J. Effects of δ-alumina and hydroxyapatite coatings in the growth and metabolism of human osteoblasts. J Biomed Mater Res 1995;29:1397-401.
33. Mawn L, Jordan DR, Ahmad I, et al. Effects of orbital biomaterials on human fibroblasts. Can J Ophthalmol 2001;36:245-51.
34. Heimke G, Griss P, Jentschura G, et al. Bioinert and Bioactive ceramics in orthopedic surgery. In: Hastings G, Williams D. eds. Mechanical Properties of Biomaterials. Toronto: John Wiley & Sons; 1980:207-15.
35. Jordan DR, Klapper SK, Mawn L, et al. Abscess formation within a synthetic hydroxyapatite implant. Can J Ophthalmol 1998;33:329-32.
36. Nunery WR, Hung GW, Borin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone spheres. Ophthal Plast Reconstr Surg 1993;9:96-104.
37. Kim YD, Goldberg RA, Shorr N, et al. Management of exposed hydroxyapatite orbital implants. Ophthalmology 1994;101:1709-15.
38. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992;113:669-73.
39. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants: report of six cases. Ophthalmology 1992;99:831-6.
40. Oestreicher JH, Lui E, Berkowitz M. Complications of hydroxyapatite implants: a review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology 1995;102:586-93.
41. Massry GC, Holds JB. Coralline hydroxyapatite sphere as secondary orbital implants in anophthalmos. Ophthalmology 1995;102:161-66.
42. Jordan DR, Brownstein S, Joly SS. Abscessed hydroxyapatite orbital implants: a report of 3two cases. Ophthalmology 1996;103:1784-7.
43. Ainbinder DJ, Haik BG, Tallado M. Hydroxyapatite orbital implant abscesses: histopathologic consideration of an infected implant following evisceration. Ophthal Plast Reconstr Surg 1994;10:267-70.
44. Remulla HD, Rubin PA, Shore JW, et al. Complications of porous spherical orbital implants. Ophthalmology 1995;102:586-93.
45. Shields CL, Shields JA, De Potter P. Hydroxyapatite orbital implant after enucleation: experience with initial 100 consecutive cases. Arch Ophthalmol 1992;110:333-8.
46. Shields CL, Shields JA, De Potter P, et al. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthal Soc 1993;91:177-89.
47. Shields CL, Shields JA, De Potter P, et al. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 1994;78:702-6.
48. Oestreicher JH. Treatment of exposed coral implant after failed scleral patch graft. Ophthal Plast Reconstr Surg 1994;10:2:110-3.
49. Dutton JJ. Corralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
50. Christmas NJ, Van Quill K, Murray TG, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol 2000;118:503-6.
51. Mawn L, Jordan DR, Gilberg S. Scanning electron microscopy of porous orbital implants. Can J Ophthalmol 1998;33:4:203-9.
52. Nunnery WR, Holds JB, Ebrahimpour J. Exposed hydroxyapatite spheres in the ophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9:96-104.
53. Lee V, Subak-Sharpe J, Hungerford JL, et al. Exposure of primary orbital implants in post enucleation retina blastoma patients. Ophthalmology 2000;107:940-5.
54. Kaltreider SA, Newman SA. Prevention and management of complications associated with hydroxyapatite implants. Ophthal Plast Reconstr Surg 1996;12;1:18-31.
55. Schlatter C. Biomedical aspects of aluminum. Med Lav 1992;83:470-4.
56. Channon SM, Mawhinney WHB, et al. Accumulating aluminum deposition in bone due to aluminum hydroxide ingestion in patients with renal failure. In: Taylor, A, ed. Renal Disease. London: Baillière Tindal; 1986.
57. Renard JL, Felton D, Bequet D. Post otoneurosurgery aluminum encephalopathy. Lancet 1994;344:63-4.
58. Pybus J. Sources of variation in the measurement of aluminum in serum, water and dialysate. In: Taylor A, ed. Aluminum and Other Trace Elements in Renal Disease. London: Baillière Tindal; 1986:292-5.